PrEP and PEP are Prevention Act
Sponsor
Full profile: /officials/W000187
Source: Congress.gov · FEC
Cosponsors (35)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
35 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-09-04
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Ways and MeansReferred To · 2025-09-04
- House Committee on Oversight and Government ReformReferred To · 2025-09-04
- House Committee on Energy and CommerceReferred To · 2025-09-04
Plain-English Summary
This bill would make HIV prevention medications (PrEP and PEP) more accessible and affordable by improving insurance coverage and reducing out-of-pocket costs for people at risk of HIV infection. The legislation affects insurance companies, healthcare providers, and individuals seeking to prevent HIV transmission through medication rather than waiting for treatment after infection. By removing financial barriers to these preventive drugs, the bill aims to reduce new HIV cases in the United States.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR4544American Access to Banking ActPassed House · 2026-05-21
- HR8777GUIDANCE Act of 2026Referred to Committee · 2026-05-13
- HJRES179Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-04: Insufficient Data Protection or Security for Sensitive Consumer Information".Referred to Committee · 2026-05-07
- HJRES170Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "The Fair Credit Reporting Act's Limited Preemption of State Laws".Referred to Committee · 2026-04-30